75
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Human chorionic gonadotropin and intravaginal natural progesterone are equally effective for luteal phase support in IVF

, , , , , & show all
Pages 316-320 | Published online: 05 Aug 2009

References

  • Smitz J, Devroey P, Camus M, et al. The luteal phase and early pregnancy after combined GnRH-agonist/hMG treatment for superovulation in IVF or GIFT. Hum Reprod 1988; 3: 585–90
  • Belaisch-Allart J, De Mouzon J, Lapousterle C, et al. The effect of hCG supplementation after combined GnRH agonist/hMG treatment in an IVF programme. Hum Reprod 1990; 5: 163–6
  • Smitz EM, Anthony FW, Gadd SC, et al. Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme. Br Med J 1989; 298: 1483–6
  • Lessey BA, Yeh I, Castelbaum AJ, et al. Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation. Fertil Steril 1996; 65: 477–83
  • Soliman S, Day S, Collins J, et al. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 1994; 61: 1068–76
  • Edgar DH, Whalley KM, Gemmell JA, et al. Effects of in-vitro exposure to hCG on subsequent hCG-responsiveness of human granulosa cells obtained following treatment with GnRH analogue and gonadotrophins: an in-vitro model for luteal phase support. Hum Reprod 1991; 6: 198–202
  • Forman RG, Frydman R, Egan D, et al. Severe ovarian hyperstimulation syndrome using agonists of gonadotrophin-releasing hormone for in vitro fertilization: a European series and proposals for prevention. Fertil Steril 1990; 53: 502–9
  • Smitz J, Devroey P, Faguer B, et al. A prospective randomized comparison of intramuscular or intravaginal natural progesterone as luteal phase and early pregnancy supplement. Hum Reprod 1992; 7: 168–75
  • Akande AV, Mathur RS, Keay SD, et al. The choice of luteal support following pituitary down regulation, controlled ovarian hyperstimulation and in vitro fertilisation. Br J Obstet Gynaecol 1996; 103: 963–6
  • Herman A, Raziel A, Strassburger D, et al. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone. Hum Reprod 1996; 11: 1552–7
  • Boada M, Coroleu B, Calderón G, et al. Resultados del programa de fecundación in vitro del Institut Universitari Dexeus (1996). I. Prog Obstet Ginecol 1996; 40: 691–9
  • Veiga A, Torello MJ, Menezo Y, et al. Use of coculture of human embryos on Vero Cells to improve clinical implantation rate. 2000, Hum Reprod, in press
  • Mathur RS, Joels LA, Akande V, et al. The prevention of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1996; 8: 740–6
  • Araujo E, Jr, Bernardini J, Frederick JL, et al. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction. J Assist Reprod Genet 1994; 11: 74–8
  • Mochtar MH, Hogerzeil HV, Mol BWJ. Progesterone alone versus progesterone combined with hCG as luteal support in GnRHa/hMG induced IVF cycles: a randomized clinical trial. Hum Reprod 1996; 11: 1602–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.